Skip to content

Clinical trials

Recruiting Carcinoma, Non-Small-Cell Lung trials in Ireland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Recruiting Country / region: Ireland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20202
20222
20245
20257
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Bristol-Myers Squibb2
Cancer Trials Ireland2
ETOP IBCSG Partners Foundation2
Merck Sharp & Dohme LLC2
Mirati Therapeutics Inc.2
Hoffmann-La Roche1
Iambic Therapeutics, Inc1
Olema Pharmaceuticals, Inc.1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung19
Lung Neoplasms7
Breast Neoplasms2
Brain Neoplasms1
Carcinoma, Hepatocellular1
Neoplasms1
Neoplasms, Germ Cell and Embryonal1
Neoplasms, Squamous Cell1
Stomach Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

  • OPTIMISE Lung SABR NCT07777614Status changeNot yet recruiting to RecruitingOctober 18, 2026

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.